.ALPHA.-METHYL-DL-TYROSINE, COMPOSITIONS, TROUSSES, COMBINAISONS ET UTILISATION ASSOCIEE DESTINES AU TRAITEMENT DU CANCER OU A LA REDUCTION DE LA PROLIFERATION CELLULAIRE
Pharmaceutical compositions and kits including a tyrosine hydroxylase inhibitor； melanin, a melanin promoter, or a combination thereof； a p450 3A4 promoter； and a leucine aminopeptidase inhibitor are provided. Also provided are methods of treating cancer in a subject, comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof. Also provided are methods of reducing cell proliferation in a subject comprising administering an effective amount of a tyrosine hydroxylase inhibitor, a melanin promoter, a p450 3A4 promoter, and a leucine aminopeptidase inhibitor to the subject in need thereof.
